Blog
Air T Posts 7% Revenue Gain in Q1
Air T (NASDAQ:AIRT), a diversified aviation-focused holding company, reported its results for the quarter ended June 30, 2025, on August 13, 2025. The headline news was a 6.8% uptick in total
Cisco Q4 Revenue Jumps on AI Demand
Cisco(NASDAQ:CSCO) reported fourth quarter fiscal 2025 results on Aug. 13, 2025, posting total revenue of $14.7 billion (up 8% YoY) and non-GAAP EPS of $0.99 (up 14% YoY), with product orders rising
Aethlon Medical Cuts Loss in Fiscal Q1
Aethlon Medical (NASDAQ:AEMD), a medical technology developer focused on its lead Hemopurifier device for cancer and viral diseases, reported fiscal first-quarter results for the period ended June
Hyperfine Posts Higher Margin in Q2
Hyperfine (NASDAQ:HYPR), known for its portable medical imaging technology, released its GAAP financial results for Q2 2025 on Aug. 13, 2025. The main headline for Q2 2025 was gross margin
Dermata Posts Narrower Loss in Q2
Dermata Therapeutics (NASDAQ:DRMA), a clinical-stage biotech specializing in innovative dermatology therapies, released its earnings on August 13, 2025. The company’s primary news item was a
Lulus (LVLU) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Wednesday, Aug. 13, 2025 at 5 p.m. ET
Chief Executive Officer and Interim Chief Financial Officer — Crystal Landsem
Source Fool.com
Gee Group Reports 9 Percent Drop in Q3
Gee Group (NYSEMKT:JOB), a staffing and workforce solutions provider, released its fiscal third quarter results on August 13, 2025. The company reported consolidated revenue of $24.5 million (GAAP)
Accuray (ARAY) Q4 2025 Earnings Call Transcript
Image source: The Motley Fool.
Wednesday, August 13, 2025 at 4:30 p.m. ET
President and Chief Executive Officer — Suzanne Winter
Source Fool.com
StandardAero Sales Jump 13 Percent
StandardAero (NYSE:SARO), a major provider of aircraft engine maintenance, repair, and overhaul services, reported results for Q2 2025 on August 13, 2025. The company posted GAAP revenue of $1,528.9
Alto Neuroscience Posts Q2 Net Loss
Alto Neuroscience (NYSE:ANRO), a clinical-stage biotechnology company focused on precision psychiatry, released its second-quarter results on August 13, 2025. It reported a net loss of $17.7
Roadzen Posts 22% Q1 Revenue Gain
Roadzen (NASDAQ:RDZN), an insurance technology company specializing in artificial intelligence-powered solutions for underwriting, claims, and telematics, released its Q1 FY2026 earnings results on
Immuneering Posts Narrower Loss in Q2
Immuneering (NASDAQ:IMRX), a clinical-stage biotechnology company specializing in cancer treatments using proprietary drug discovery platforms, released its second quarter 2025 results on August 13
Red Robin Q2 Margins Rise on Labor Gains
Red Robin Gourmet Burgers(NASDAQ:RRGB) reported fiscal second quarter 2025 results on Aug. 13, 2025, with GAAP revenues of $283.7 million, a comparable restaurant revenue decline of 3.2%, and a 270
Dolphin Entertainment Reports Record Q2
Dolphin Entertainment(NASDAQ:DLPN) announced its results for the second quarter ended June 30, 2025, on August 13, 2025, achieving record revenue of $14.1 million, up 23% year-over-year, and
Red Robin (RRGB) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Wednesday, August 13, 2025 at 4:30 p.m. ET
Chief Executive Officer — Dave Pace
Source Fool.com
Jasper Reports Wider Loss in Fiscal Q2
Jasper Therapeutics (NASDAQ:JSPR), a clinical-stage biotechnology company focused on therapies for mast cell-driven diseases like chronic urticaria, released its second quarter 2025 financial
Boston Omaha Posts 4% Sales Gain
Boston Omaha (NYSE:BOC), a diversified holding company with businesses in outdoor advertising, broadband services, and insurance, posted its second quarter 2025 results on Aug. 13, 2025. Revenue
Boxlight Sales Drop 20 Percent
Boxlight (NASDAQ:BOXL), an education technology company specializing in interactive classroom solutions and digital displays, reported its financial results for the second quarter of fiscal 2025 on
Hyperfine HYPR Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Aug. 13, 2025 at 4:30 p.m. ET
President and Chief Executive Officer — Maria Sainz
Source Fool.com
HeartBeam Cuts Costs Awaits FDA Decision
HeartBeam (NASDAQ:BEAT) reported its Q2 2025 results on July 16, 2025, reaffirming key regulatory and commercial milestones and announcing a 23% sequential decrease in cash burn to $3.4 million. The
Why Novo Nordisk Stock Topped the Market Today
Novo Nordisk (NYSE: NVO) is quite the divisive stock among both investors and analysts these days. Although its high-profile obesity drug Wegovy has been a raging success, the company is being
HeartBeam (BEAT) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Wednesday, August 13, 2025 at 4:30 p.m. ET
Chief Executive Officer — Rob Eno
Source Fool.com
Xos Reports Record Q2 Revenue Growth
Xos (NASDAQ:XOS), a manufacturer of battery-electric commercial vehicles, reported its second quarter earnings on August 13, 2025. The release was notable for record GAAP revenue of $18.4 million
Crescent Capital BDC Earnings Miss
Crescent Capital BDC (NASDAQ:CCAP), a business development company focused on lending to middle-market companies, released its second quarter 2025 earnings results on August 13, 2025. The most
Aqua Metals AQMS Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Aug. 13, 2025 at 4:30 p.m. ET
Chief Executive Officer — Steve Cotton
Source Fool.com